ENST00000465127.1:c.172-313783G>A

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_StrongBP6_Moderate

The ENST00000465127.1(ENSG00000250349):​c.172-313783G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.71 ( 19605 hom., 22860 hem., cov: 23)
Failed GnomAD Quality Control

Consequence

ENSG00000250349
ENST00000465127.1 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:2

Conservation

PhyloP100: 0.0100

Publications

5 publications found
Variant links:
Genes affected
OTC (HGNC:8512): (ornithine transcarbamylase) This nuclear gene encodes a mitochondrial matrix enzyme. The encoded protein is involved in the urea cycle which functions to detoxify ammonia into urea for excretion. Mutations in this enzyme lead to ornithine transcarbamylase deficiency, which causes hyperammonemia. [provided by RefSeq, May 2022]
OTC Gene-Disease associations (from GenCC):
  • ornithine carbamoyltransferase deficiency
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P, Laboratory for Molecular Medicine, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant X-38352338-G-A is Benign according to our data. Variant chrX-38352338-G-A is described in ClinVar as [Benign]. Clinvar id is 516401.Status of the report is criteria_provided_single_submitter, 1 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
OTCNM_001407092.1 linkc.-79-280G>A intron_variant Intron 2 of 11 NP_001394021.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ENSG00000250349ENST00000465127.1 linkc.172-313783G>A intron_variant Intron 3 of 8 5 ENSP00000417050.1 B4E171

Frequencies

GnomAD3 genomes
AF:
0.706
AC:
77882
AN:
110321
Hom.:
19611
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.687
Gnomad AMI
AF:
0.788
Gnomad AMR
AF:
0.693
Gnomad ASJ
AF:
0.782
Gnomad EAS
AF:
0.728
Gnomad SAS
AF:
0.766
Gnomad FIN
AF:
0.630
Gnomad MID
AF:
0.811
Gnomad NFE
AF:
0.718
Gnomad OTH
AF:
0.684
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
Data not reliable, filtered out with message: InbreedingCoeff
AF:
0.706
AC:
77919
AN:
110374
Hom.:
19605
Cov.:
23
AF XY:
0.700
AC XY:
22860
AN XY:
32644
show subpopulations
African (AFR)
AF:
0.687
AC:
20813
AN:
30288
American (AMR)
AF:
0.694
AC:
7195
AN:
10373
Ashkenazi Jewish (ASJ)
AF:
0.782
AC:
2064
AN:
2639
East Asian (EAS)
AF:
0.727
AC:
2544
AN:
3497
South Asian (SAS)
AF:
0.764
AC:
2017
AN:
2639
European-Finnish (FIN)
AF:
0.630
AC:
3585
AN:
5689
Middle Eastern (MID)
AF:
0.802
AC:
174
AN:
217
European-Non Finnish (NFE)
AF:
0.718
AC:
37970
AN:
52861
Other (OTH)
AF:
0.685
AC:
1022
AN:
1492
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
850
1700
2551
3401
4251
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
678
1356
2034
2712
3390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.705
Hom.:
7302
Bravo
AF:
0.705

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Benign:1
Feb 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Ornithine carbamoyltransferase deficiency Benign:1
Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.59
DANN
Benign
0.70
PhyloP100
0.010
PromoterAI
-0.00090
Neutral

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5917573; hg19: chrX-38211591; API